Designing a sequentially randomized study with adherence enhancing interventions for diabetes patients

Statistics in Medicine

Volumn 29, Issue 10, 2010, Pages 1114-1126

  Buyze, Jozefien ^a   Van Rompaye, Bart ^a   Goetghebeur, Els ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Adaptive treatment strategies; Adherence; Diabetes; Sequential randomization

Indexed keywords

ARTICLE; BEHAVIOR; BIOTECHNOLOGY; COST EFFECTIVENESS ANALYSIS; FACTORIAL DESIGN; MANAGED CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; SAMPLE SIZE; SEQUENTIAL ANALYSIS; SIMULATION; TREATMENT FAILURE;

COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; HUMANS; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE;

EID: 77951578102     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3856     Document Type: Article

References (31)

1. Murphy SA, van der Laan MJ, Robins JM, Conduct Problems Prevention Research Group. Marginal mean models for dynamic regimes. Journal of the American Statistical Association 2001; 96:1410-1423.
2. Murphy SA. An experimental design for the development of adaptive treatment strategies. Statistics in Medicine 2005; 24:1455-1481. DOI: 10.1002/sim.2022.
3. Moodie EEM, Richardson TS, Stephens DA. Demystifying optimal dynamic treatment regimes. Biometrics 2007; 63:447-455. DOI: 10.1111/j.1541-0420.2006. 00686.x.
4. Lavori PW, Dawson R. Adaptive treatment strategies in chronic disease. Annual Review of Medicine 2008; 59:443-453. DOI: 10.1146/annurev.med.59.062606. 122232. (Pubitemid 351287948)
5. De Geest S, Schäfer-Keller P, Denhaerynck K, Thannberger N, Köfer S, Bock A, Surber C, Steiger J. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation 2006; 20:359-368. DOI: 10.1111/j.1399-0012.2006.00493.x. (Pubitemid 43880573)
6. IOM (Institute of Medicine). Methodological Challenges in Biomedical HIV Prevention Trials. The National Academies Press: Washington, DC, 2008.
7. Murphy SA, Lynch KG, Oslin D, McKay JR, TenHave T. Developing adaptive treatment strategies in substance abuse research. Drug and Alcohol Dependence 2007; 88S:S24-S30. (Pubitemid 46541624)
8. Brooner RK, Kidorf M. Using behavioral reinforcement to improve methadone treatment participation. Science and Practice Perspectives 2002; 1:38-49.
9. IDF Diabetes Atlas. http://www.eatlas.idf.org [18 September 2007].
10. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson J, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002; 25:148-198. (Pubitemid 41185044)
11. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine 2001; 344:1343-1350. (Pubitemid 32378388)
12. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine 2002; 346:393-403.
13. Elgzyri T. Basic management of diabetes mellitus: practical guidelines. Libyan Journal of Medicine 2006; 1:G176-G184.
14. American Diabetes Association. Diabetes management in correctional institutions. Diabetes Care 2006; 29:S59-S66.
15. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27:1218-1224. (Pubitemid 38579798)
16. Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Electronic monitoring and counseling to improve medication adherence. Behaviour Research and Therapy 2004; 42:409-422. DOI: 10.1016/S0005-7967(03)00149-159
17. Hinson Langford CP, Bowsher J, Moloney JP, Lillis PP. Social support: a conceptual analysis. Journal of Advanced Nursing 1997; 25:95-100.
18. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychology 2004; 23:207-218. DOI: 10.1037/0278-6133.23.2. 207.
19. Velentgas P, Bynum C, Zierler S. The buddy volunteer commitment in AIDS care. American Journal of Public Health 1990; 80:1378-1380. (Pubitemid 20375561)
20. Burrage J, Demi A. Buddy programs for people infected with HIV. Journal of the Association of Nurses in Aids Care 2003; 14:52-62. DOI: 10.1177/1055329002239190. (Pubitemid 38553004)
21. May S, West R, Hajek P, McEwen A, McRobbie H. Randomized controlled trial of a social support ('buddy') intervention for smoking cessation. Patient Education and Counseling 2006; 64:235-241. DOI: 10.1016/j.pec.2006.02.008. (Pubitemid 44772962)
22. Murray RP, Johnston JJ, Dolce JJ, Lee WW, O'Hara P. Social support for smoking cessation and abstinence: the lung health study. Addictive Behaviors 1995; 20:159-170.
23. West R, Edwards M, Hajek P. A randomized controlled trial of a 'buddy' system to improve success at giving up smoking in general practice. Addiction 1998; 93:1007-1011.
24. Weingarten SR, Henning JM, Badamgarav E, Knight K, Hasselblad V, Gano Jr A, Ofman JJ. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. British Medical Journal 2002; 325: 925F-928F. (Pubitemid 35265206)
25. Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In Statistical Models in Epidemiology: The Environment and Clinical Trials, Halloran E, Berry D (eds). Springer: New York, 1999; 95-134.
26. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11:550-560. (Pubitemid 30660034)
27. Riekert KA, Rand CS. Electronic monitoring of medication adherence: when is high-tech best? Journal of Clinical Psychology in Medical Settings 2002; 9:25-34. (Pubitemid 34436401)
28. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Annals of Internal Medicine 2005; 142:323-332. (Pubitemid 40293405)
29. Belgisch Centrum voor Farmacotherapeutische Informatie. Available from: http://www.bcfi.be [30 August 2007].
30. Brandle M, Zhou H, Smith BRK, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH. The direct medical cost of type 2 diabetes. Diabetes Care 2003; 26:2300-2304. (Pubitemid 36993316)
31. Murphy SA, Bingham D. Screening experiments for developing dynamic treatment regimes. Journal of the American Statistical Association 2009; 104:391-408. DOI: 10.1198/jasa.2009.0119.